Leukemia
NX-5948-306: A Phase 3, Randomized, Open-label, Multicenter Study of NX-5948 Versus Pirtobrutinib in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL).
- Details
ClinicalTrials.gov ID:
NCT07516093
Diagnosis Type:
NA
USOR Number:
- Address
,
P: